Clinical Trial Update: Brexpiprazole as Adjunctive Therapy With Major Depressive Disorder and an Inadequate Response to Previous Adjunctive Therapy [Phase 3]

View source ↗

Summary

Phase 3 trial results for brexpiprazole as adjunctive therapy in adults with major depressive disorder with inadequate response to prior adjunctive therapy have…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• brexpiprazole (brexpiprazole)

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Major Depressive Disorder (MDD) | Phase 3 | Status: COMPLETED | Results posted: 2015-10-08